31![OTTaxitinib-for-preoperative-downstaging-of-sarcomatoid-renal-c OTTaxitinib-for-preoperative-downstaging-of-sarcomatoid-renal-c](https://www.pdfsearch.io/img/5046b955013489d2cd7a120095d02dab.jpg) | Add to Reading ListSource URL: www.euikcs.comLanguage: English - Date: 2014-05-13 14:59:54
|
---|
32![Immunotherapy for Kidney Cancer: Finally Center-Stage? Nizar M. Tannir, MD, FACP Professor and Deputy Chair GU Medical Oncology Immunotherapy for Kidney Cancer: Finally Center-Stage? Nizar M. Tannir, MD, FACP Professor and Deputy Chair GU Medical Oncology](https://www.pdfsearch.io/img/f2cc729a07ea3f1a2a015b701f6063ac.jpg) | Add to Reading ListSource URL: www.euikcs.comLanguage: English - Date: 2015-05-04 13:05:40
|
---|
33![1st line treatment: what has changed in the last 2 years? 10th European International Kidney Cancer Symposium Lyon April 2015 1st line treatment: what has changed in the last 2 years? 10th European International Kidney Cancer Symposium Lyon April 2015](https://www.pdfsearch.io/img/725a915ccedf0084e29f1164632cfd53.jpg) | Add to Reading ListSource URL: www.euikcs.comLanguage: English - Date: 2015-05-04 13:05:49
|
---|
34![My ideal bevacizumab patient? Bernard Escudier Institut Gustave Roussy, Villejuif, France Ninth European International Kidney Cancer Symposium Dublin – 25-26 April 2014
My ideal bevacizumab patient? Bernard Escudier Institut Gustave Roussy, Villejuif, France Ninth European International Kidney Cancer Symposium Dublin – 25-26 April 2014](https://www.pdfsearch.io/img/f3a5da7555a938acc82e412f2b82fbb2.jpg) | Add to Reading ListSource URL: www.euikcs.comLanguage: English - Date: 2014-05-13 15:04:17
|
---|
35![Nephron Sparing Surgery Past, Present and Future Hein Van Poppel Professor and Chairman UZ Leuven Adjunct Secretary General EAU Nephron Sparing Surgery Past, Present and Future Hein Van Poppel Professor and Chairman UZ Leuven Adjunct Secretary General EAU](https://www.pdfsearch.io/img/09ed44bd027a8e05eb68cf7f203b8add.jpg) | Add to Reading ListSource URL: www.euikcs.comLanguage: English - Date: 2015-05-04 13:05:45
|
---|
36![Who is the ideal mTOR patient ? Thomas E Hutson, DO, PharmD, FACP Professor of Medicine Director, GU Oncology Program Co-Director, GU Center of Excellence
Who is the ideal mTOR patient ? Thomas E Hutson, DO, PharmD, FACP Professor of Medicine Director, GU Oncology Program Co-Director, GU Center of Excellence](https://www.pdfsearch.io/img/cc54b5dec5809c4ebd316bd2fe17b98a.jpg) | Add to Reading ListSource URL: www.euikcs.comLanguage: English - Date: 2014-05-13 13:28:54
|
---|
37![467 VERIFICATION OF A FUNCTIONALIZED STRUCTURED MEDICAL WIRE FOR THE ISOLATION OF CIRCULATING TUMOR CELLS (CTC) IN PATIENTS WITH RENAL CELL CARCINOMA 467 VERIFICATION OF A FUNCTIONALIZED STRUCTURED MEDICAL WIRE FOR THE ISOLATION OF CIRCULATING TUMOR CELLS (CTC) IN PATIENTS WITH RENAL CELL CARCINOMA](https://www.pdfsearch.io/img/195b07f6478c5fd4a92ee0a6c9dfa7f6.jpg) | Add to Reading ListSource URL: www.gilupi.deLanguage: English - Date: 2014-02-06 03:45:50
|
---|
38![Is Renal Cryoablation Becoming an Effective Alternative to Partial Nephrectomy? Julien Garnon & Jean Jacques Patard 51 years old man No medical past history BMI=35 Creatinin 0.8 mg/dl MDRD GFR: 102 ml/min Is Renal Cryoablation Becoming an Effective Alternative to Partial Nephrectomy? Julien Garnon & Jean Jacques Patard 51 years old man No medical past history BMI=35 Creatinin 0.8 mg/dl MDRD GFR: 102 ml/min](https://www.pdfsearch.io/img/9ecce57729a7f93337c958930893367c.jpg) | Add to Reading ListSource URL: www.euikcs.comLanguage: English - Date: 2015-05-04 13:05:40
|
---|
39![Sergio Bracarda MD Head, Medical Oncology Department of Oncology AUSL-8 Istituto Toscano Tumori (ITT) San Donato Hospital Arezzo, Italy
Sergio Bracarda MD Head, Medical Oncology Department of Oncology AUSL-8 Istituto Toscano Tumori (ITT) San Donato Hospital Arezzo, Italy](https://www.pdfsearch.io/img/c625e40150a3bef6f33323cc900f1604.jpg) | Add to Reading ListSource URL: www.euikcs.comLanguage: English - Date: 2014-05-13 14:06:16
|
---|
40![Immunotherapy versus targeted treatments in metastatic renal cell carcinoma: The return game? Sylvie NEGRIER MD, PhD Centre Léon Bérard, Lyon Université Lyon I Immunotherapy versus targeted treatments in metastatic renal cell carcinoma: The return game? Sylvie NEGRIER MD, PhD Centre Léon Bérard, Lyon Université Lyon I](https://www.pdfsearch.io/img/9f063a1587d69386993c958fe443df20.jpg) | Add to Reading ListSource URL: www.euikcs.comLanguage: English - Date: 2015-05-04 13:05:42
|
---|